(I) US FDA ANDA PREPARATION OF SOLID ORAL TABLETS 200 MG OF DRUG X, USP (II) INVESTIGATION OF DISSOLUTION PARAMETERS DUR

محفوظ في:

التفاصيل البيبلوغرافية
المؤلف الرئيسي:	PHADNIS SUDHIKSHA
التنسيق:	كتاب
منشور في:
الموضوعات:
الوسوم:	إضافة وسم لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!

مواد مشابهة

A. ANDA PREPARATION FOR SOLID ORAL TABLETS OF DRUG 'X' B. VALIDATION OF DISSOLUTION METHOD FOR SOLID TABLETS OF DRUG 'Y'
حسب: BHAVNANI KAMLESH

1. LINE EXTENSION OF THE EXISTING USFDA-ANDA FOR AN ANTI HYPERTENSIVE EXTENDED TABLETS USP, 25 MG AND 2. VALIDATION OF D
حسب: DIVEKAR RUCHA

Dur: Kshitigapalikadale
حسب: Londhe, Laxman
منشور في: (2002)

Dur Gaganke tare
حسب: Paradeshi, Pran
منشور في: (1963)

Dur Gaganke tare
حسب: Paradeshi, Pran
منشور في: (1963)

1) PREPARATION AND SUBMISSION OF ANDA FOR XYZ TABLET TO USFDA 2) DISSOLUTION METHOD VALIDATION FOR DRUG XYZ, CALIBRATION
حسب: PANDEY SHAILESH

BIOEQUIVALENCE STUDY OF OXCARBAZEPINE TABLETS (600 mg) WITH TRILEPTAL (OXCARBAZEPINE) TABLETS (600 mg) IN ADULT, HUMAN S
حسب: KHAN TANVEER

Drug dissolution testing of oral dosage forms
حسب: Vaidya Rohit Sudhir

BIOEQUIVALENCE STUDY OF PRASUGREL 10 mg TABLETS
حسب: PARMAR GIRISH

DUR DESH KI GANDH
حسب: MEHTA, SATISH
منشور في: (2012)

DUR DESH KI GANDH
حسب: MEHTA, SATISH
منشور في: (2012)

Rahile dur ghar majhe
حسب: Khan, S
منشور في: (2015)

Rahile dur ghar majhe
حسب: Khan, S
منشور في: (2015)

Inventory Parameters
حسب: Sharma,Sanjay
منشور في: (2017)

"Part I - Regulatory Framework for the Novel Polymers and Features of Approved Polymers in Orally Disintegrating Tablets as per U.S. FDA Part II - Preparation of Module 3 for the Submission of ANDA in the U.S. Market at Bliss GVS Pharma Ltd"
حسب: Shetty Kavyashree

BIOEQUIVALENCE STUDY OF SINGLE DOSE FAMCICLOVIR TABLETS 500 mg COMPARING WITH FAMVIR (FAMCICLOVIR) TABLETS 500 mg IN HEA
حسب: JAIN PANKAJ

Formulation Development of Artemether and Lumefantrine for Improvement of Solubility and Dissolution Rate for Oral Drug Delivery (Tablet)
حسب: Rohit Patel
منشور في: (2017)

PREPARATION OF ABBREVIATED NEW DRUG APPLICATION FOR US MARKET, AMOXICILLIN CAPSULES USP, 500 mg
حسب: DUBEY PRAKHAR

DEVELOPLMENT AND BIOEQUIVALENCE STUDY OF OLANZAPINE 10 mg TABLET
حسب: WAYKAR RAVINDRA

FORMULATION OF ARIPIPRAZOLE ORALLY DISINTEGRATING TABLETS
حسب: AGARWAL PRATEEK

FDA REGULATORY AFFAIRS
حسب: MANTUS DAVID; PISANO DOUGLAS
منشور في: (2017)

FDA REGULATORY AFFAIRS
حسب: MANTUS DAVID
منشور في: (2021)

FDA REGULATORY AFFAIRS
حسب: PISANO DOUGLAS J
منشور في: (2004)

FDA regulatory affairs
حسب: Mantus.David
منشور في: (2014)

BIOEQUIVALENCE STUDY OF SINGLE DOSE DRONEDARONE TABLET 400 mg WITH MULTAQ 400 mg WITH MULATAQ 400 mg UNDER FAST CONDITIO
حسب: PATIL SATISH

FORMULATION AND DEVELOPMENT OF MODIFIED RELEASE DOSAGE FORM CONTAINING METFORMIN HYDROCHLORIDE 500 Mg AS AN ANDA PERSPEC
حسب: CHINCHOLE AMOL

BIOEQUIVALENCE STUDY OF A SINGLE DOSE OF VORICONAZOLE TABLETS 200 MG IN ADULT HUMAN SUBJECTS UNDER FASTING CONDITIONS
حسب: PATEL PARMI

METHOD DEVELOPMENT AND VALIDATION OF ASSAY AND DISSOLUTION FOR ETORICOXIB TABLETS
حسب: THUMAR RUTU

FORMULATION AND EVALUATION OF PARACETAMOL 325 MG + CAFFEINE 50 MG FAST ACTING IMMIDIATE RELEASE TABLETS
حسب: SHARMA AKSHAT

FORMULATION DEVELOPMENT OF FELODIPINE PROLONGED RELEASE TABLETS 10 MG
حسب: MANDPE PANKAJ

PROCESS VALIDATION OF IMMUNOSUPRESSANT FILM COATED TABLET 50 mg
حسب: GAJERA JAGDISHKUMAR

FORMULATION, DEVELOPMENT AND EVALUATION OF ORALLY DISINTEGRATING TABLET
حسب: JAIN MEETA

FORMULATION DEVELOPMENT AND EVALUATION OF ORAL CONTRACEPTIVE TABLET
حسب: SHAIKH MUSA

FORMULATION AND EVALUATION OF OLANZAPINE ORALLY DISINTEGRATING TABLET
حسب: PATEL RIKIN

Development and Characterization of Danazol Orally Disintegrating Tablets
حسب: Yennawar Rohit

BIOAVAILABILITY AND BIOEQUIVALENCE STUDY OF AMOXYCILLIN 875 MG AND CLAVULANIC ACID 125 MG TABLET UNDER FED CONDITION ON
حسب: TRANGADIYA NIDHI

ANALYTICAL METHOD DEVELOPMENT AND VALIDATION OF DRUG X, ASSAY, DISSOLUTION AND RELTED SUBSTANCE TEST AS PER US FDA REQUI
حسب: SAWARDEKAR POOJA

FDA ADMINISTRATIVE ENFORCEMENT MANUAL
حسب: PARKER FLORENCE R [A]
منشور في: (2005)

METHOD DEVELOPMENT AND VALIDATION FOR DISSOLUTION TEST OF THE TABLET CONTAINING QUETIAPINE
حسب: AWASTHI YOGESH

STABILITY STUDY OF NTP FILM COATED TABLETS 2.5 mg
حسب: PANDYA MALAYKUMAR